You are here

Pfizer

Pfizer, BioNTech's COVID Shot Safe in Young Kids Per FDA

Yahoo/Zacks.com

Mon, 06/13/22 - 10:51 am

With stacked to-do list, ImCheck checks off next funding round, refueling with about $101M

Fierce Biotech

Mon, 06/13/22 - 10:26 am

venture capital

Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D

Endpoints

Thu, 06/9/22 - 10:46 am

machine learning

Relation Therapeutics

Pfizer to invest $120M, add jobs in Paxlovid production push

BioPharma Dive

Tue, 06/7/22 - 11:56 pm

drug manufacturing

Pfizer's Ibrance Fails to Significantly Extend Lives of Breast Cancer Patients

BioSpace

Mon, 06/6/22 - 11:48 pm

HER2-negative breast cancer

ASCO22: J&J, Pfizer trade BCMA bispecific data in myeloma

Pharmaforum

Mon, 06/6/22 - 09:52 am

bispecific antibodies

relapsed or refractory multiple myeloma

ASCO: Pfizer's Ibrance fails to extend lives in newly diagnosed breast cancer. Will doctors switch gears to Novartis, Lilly?

Fierce Pharma

Sun, 06/5/22 - 11:40 pm

HER2-negative breast cancer

clinical trials

Why Pfizer Needs a High-Growth Pipeline

Motley Fool

Fri, 06/3/22 - 09:13 am

Pfizer completes COVID-19 vaccine application for kids under 5

Beckers Hospital Review

Thu, 06/2/22 - 07:27 pm

Pfizer's new vaccine R&D leader Anderson has a high bar to reach in replacing Jansen

Fierce Pharma

Thu, 06/2/22 - 07:15 pm

Pfizer shoots back at Alnylam's claims in high-stakes COVID-19 vaccine patent case

Fierce Pharma

Thu, 06/2/22 - 10:21 am

Here's Why Pfizer's COVID Revenue Could Remain Strong Next Year

Motley Fool

Wed, 06/1/22 - 07:33 pm

Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts

Fierce Pharma

Wed, 06/1/22 - 10:15 am

Pfizer, already flush with cash, will reap $16B from selling shares in GSK consumer health spinoff

Fierce Pharma

Wed, 06/1/22 - 09:57 am

consumer health

Go or no go? The FDA’s Amylyx dilemma

EP Vantage

Tue, 05/31/22 - 10:29 am

Moderna Therapeutics

Pfizer (PFE) Gets Fast Track Designation for NASH Therapy

Yahoo/Zacks.com

Mon, 05/30/22 - 10:25 am

ervogastat/clesacostat

Abbvie to become the biggest of pharmas in 2028

EP Vantage

Mon, 05/30/22 - 10:13 am

Bristol Myers Squibb

Pfizer's NASH Treatment Lands FDA Fast Track Designation

BioSpace

Thu, 05/26/22 - 10:44 pm

ervogastat/clesacostat

CDC warns of rebounding symptoms after Paxlovid

Beckers Hospital Review

Thu, 05/26/22 - 10:11 am

US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf

Endpoints

Wed, 05/25/22 - 11:47 pm

Pages